Groff North America is the first DEA-approved company to grow cannabis for medical research
Bethan Rose Jenkins, Cannabis News Writer/Editorial
• March 14, 2022
DEA supports White House scheme to simplify research into Schedule I substances like cannabis and psychedelics
Bethan Rose Jenkins, Cannabis News Writer/Editorial
• December 15, 2021
Study: Illegal cannabis seizures have ‘decreased dramatically’ amid rise of state-legalization
Bethan Rose Jenkins, Cannabis News Writer/Editorial
• October 30, 2021
Body of research indicates that Bangladeshi folk medicine practitioners used Cannabis sativa Linnaeus as traditional phytomedicine
Bethan Rose Jenkins, Cannabis News Writer/Editorial
• July 26, 2021
DEA to permit additional research of cannabis, but obstacles remain
Bethan Rose Jenkins, Cannabis News Writer/Editorial
• June 15, 2021
Eight U.S. States support cancer patients in psilocybin legal battle against DEA
Bethan Rose Jenkins, Cannabis News Writer/Editorial
• June 15, 2021
U.S. House chooses to expand medical cannabis research
Bethan Rose Jenkins, Cannabis News Writer/Editorial
• December 15, 2020
Hemp industry players want the DEA to classify hemp byproducts fairly
Bethan Rose Jenkins, Cannabis News Writer/Editorial
• November 15, 2020
Adult-use cannabis sales in Illinois hit another new record in September
Bethan Rose Jenkins, Cannabis News Writer/Editorial
• October 20, 2020
Federal court rejects DEA request to drop cannabis rescheduling case
Bethan Rose Jenkins, Cannabis News Writer/Editorial
• August 31, 2020
DEA releases long-awaited regulations for research cannabis supply expansion
Bethan Rose Jenkins, Cannabis News Writer/Editorial
• April 20, 2020
Cannabis companies want to stimulate federal research efforts
Bethan Rose Jenkins, Cannabis News Writer/Editorial
• February 7, 2020
Load More Stories